arrow_backBack to Catalogue
Metabolic / Weight Management
Retatrutide
Advanced tri-agonist (GIP/GLP-1/Glucagon) for next-generation metabolic optimization.
Clinical Profile
- check_circleSuperior management of metabolic goals
- check_circleComprehensive appetite and craving control
- check_circleEnhanced glucagon-mediated fat oxidation
- check_circleProfound glycemic and weight stability
biotech
Mechanism of Action
A triple agonist of the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This multi-pathway targeting provides unprecedented control over appetite, glucose metabolism, and fat burning.
medication_liquid
Therapeutic Application
Administered via once-weekly subcutaneous injection with a carefully structured titration protocol.
Ready to include Retatrutide in your protocols?
Log in to the prescriber portal to access research monographs, inventory availability, and peer-reviewed clinical studies.